December 14, 2012 11:55 AM | 1 min read |
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
The board of directors ofAbbott (NYSE: ABT) today declared its 356^th consecutive quarterly cashdividend. The quarterly dividend is $0.14 per share, payable Feb. 15, 2013, toshareholders of record on Jan. 15, 2013. The management of AbbVie, Abbott'sresearch-based pharmaceuticals business, intends to recommend a cash dividend,subject to AbbVie board approval, of $0.40 per share, which together withAbbott's dividend will equal a cash dividend of $0.54 per share, an increaseof nearly 6 percent over Abbott's quarterly cash dividend declared inSeptember 2012.Abbott's annualized cash dividend of $0.56 per share, combined with AbbVie'sannualized cash dividend of $1.60 per share equals a total annualized cashdividend of $2.16 per share, compared to the annualized cash dividend ofAbbott, prior to separation, of $2.04 per share. Future quarterly dividends,including the expected AbbVie dividend in February 2013, are subject toapproval by each company's board of directors.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.